Loading...
DHR logo

Danaher Community

NYSE:DHR Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 106 Fair Values set on narratives written by author

Community Investing Ideas

DHR logo
Danaher

Advanced Diagnostics And Personalized Therapies Will Expand Global Markets

Key Takeaways Strong recurring revenue and margin stability are driven by consumables, services, and robust demand for advanced diagnostics and life science tools. Innovation in precision medicine and disciplined operational execution position the company for high-margin growth and expanding global market opportunities.

View narrative
0users have liked this narrative
0users have commented on this narrative
58users have followed this narrative
US$244.5
12.9% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
6.74% p.a.
Profit Margin
19.65%
Future PE
36.85x
Share price in 2028
US$303.04